Alcohol Use Disorder study: Connections App
Official title Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
ClinicalTrials.gov ID: NCT06305624
What this study is testing
- What it's testing
- This study is testing whether the CHESS Health Connections smartphone app helps people with alcohol‑associated liver disease stay abstinent.
- Who it's for
- You may be able to join if you have alcohol use disorder and liver disease and receive care at a participating clinic.
- What's involved
- You will use the CHESS app on your phone. You will have regular check‑ins and surveys during the study.
- Time commitment
- The study lasts up to 6 months with visits and app use during that time.
- Time commitment: about 6 months
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of ALD (any stage)
- Alcoholic liver disease (ALD) encompasses a spectrum of hepatic injuries caused by long-term alcohol abuse.
- Alcohol use within the last 6 months
- Receiving care at UW or Henry Ford Health + MSU
- Either the general hepatology clinic or the multidisciplinary ALD clinic
You likely can't join if
- Actively listed for liver transplant or history of liver transplant before being enrolled in the study.
- In hospice care
- Has severe cognitive impairment (as described in electronic health record including dementia, delirium, and/or unable to maintain cognitive alertness...
See the full eligibility criteria
- Diagnosis of ALD (any stage)
- Alcoholic liver disease (ALD) encompasses a spectrum of hepatic injuries caused by long-term alcohol abuse.
- Alcohol use within the last 6 months
- Receiving care at UW or Henry Ford Health + MSU
- Either the general hepatology clinic or the multidisciplinary ALD clinic
- Able to read and write proficiently in English
- Willing and able to use a smartphone app
- Actively listed for liver transplant or history of liver transplant before being enrolled in the study.
- In hospice care
- Has severe cognitive impairment (as described in electronic health record including dementia, delirium, and/or unable to maintain cognitive alertness during screening--as determined by study staff.)
The study team makes the final eligibility decision.
Where it is enrolling
- Lansing, Michigan, United States
- Madison, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Lansing, Michigan, United States; Madison, Wisconsin, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.